Cargando…

Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene

BACKGROUND: Methylation-sensitive high resolution melting (MS-HRM) methodology is able to recognise heterogeneously methylated sequences by their characteristic melting profiles. To further analyse heterogeneously methylated sequences, we adopted a digital approach to MS-HRM (dMS-HRM) that involves...

Descripción completa

Detalles Bibliográficos
Autores principales: Candiloro, Ida LM, Mikeska, Thomas, Hokland, Peter, Dobrovic, Alexander
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2590600/
https://www.ncbi.nlm.nih.gov/pubmed/19014416
http://dx.doi.org/10.1186/1756-8935-1-7
_version_ 1782161345937932288
author Candiloro, Ida LM
Mikeska, Thomas
Hokland, Peter
Dobrovic, Alexander
author_facet Candiloro, Ida LM
Mikeska, Thomas
Hokland, Peter
Dobrovic, Alexander
author_sort Candiloro, Ida LM
collection PubMed
description BACKGROUND: Methylation-sensitive high resolution melting (MS-HRM) methodology is able to recognise heterogeneously methylated sequences by their characteristic melting profiles. To further analyse heterogeneously methylated sequences, we adopted a digital approach to MS-HRM (dMS-HRM) that involves the amplification of single templates after limiting dilution to quantify and to determine the degree of methylation. We used this approach to study methylation of the CDKN2B (p15) cell cycle progression inhibitor gene which is inactivated by DNA methylation in haematological malignancies of the myeloid lineage. Its promoter region usually shows heterogeneous methylation and is only rarely fully methylated. The methylation status of CDKN2B can be used as a biomarker of response to treatment. Therefore the accurate characterisation of its methylation is desirable. RESULTS: MS-HRM was used to assess CDKN2B methylation in acute myeloid leukaemia (AML) samples. All the AML samples that were methylated at the CDKN2B promoter (40/93) showed varying degrees of heterogeneous methylation. Six representative samples were selected for further study. dMS-HRM was used to simultaneously count the methylated alleles and assess the degree of methylation. Direct sequencing of selected dMS-HRM products was used to determine the exact DNA methylation pattern and confirmed the degree of methylation estimated by dMS-HRM. CONCLUSION: dMS-HRM is a powerful technique for the analysis of methylation in CDKN2B and other heterogeneously methylated genes. It eliminates both PCR and cloning bias towards either methylated or unmethylated DNA. Potentially complex information is simplified into a digital output, allowing counting of methylated and unmethylated alleles and providing an overall picture of methylation at the given locus. Downstream sequencing is minimised as dMS-HRM acts as a screen to select only methylated clones for further analysis.
format Text
id pubmed-2590600
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25906002008-11-29 Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene Candiloro, Ida LM Mikeska, Thomas Hokland, Peter Dobrovic, Alexander Epigenetics Chromatin Methodology BACKGROUND: Methylation-sensitive high resolution melting (MS-HRM) methodology is able to recognise heterogeneously methylated sequences by their characteristic melting profiles. To further analyse heterogeneously methylated sequences, we adopted a digital approach to MS-HRM (dMS-HRM) that involves the amplification of single templates after limiting dilution to quantify and to determine the degree of methylation. We used this approach to study methylation of the CDKN2B (p15) cell cycle progression inhibitor gene which is inactivated by DNA methylation in haematological malignancies of the myeloid lineage. Its promoter region usually shows heterogeneous methylation and is only rarely fully methylated. The methylation status of CDKN2B can be used as a biomarker of response to treatment. Therefore the accurate characterisation of its methylation is desirable. RESULTS: MS-HRM was used to assess CDKN2B methylation in acute myeloid leukaemia (AML) samples. All the AML samples that were methylated at the CDKN2B promoter (40/93) showed varying degrees of heterogeneous methylation. Six representative samples were selected for further study. dMS-HRM was used to simultaneously count the methylated alleles and assess the degree of methylation. Direct sequencing of selected dMS-HRM products was used to determine the exact DNA methylation pattern and confirmed the degree of methylation estimated by dMS-HRM. CONCLUSION: dMS-HRM is a powerful technique for the analysis of methylation in CDKN2B and other heterogeneously methylated genes. It eliminates both PCR and cloning bias towards either methylated or unmethylated DNA. Potentially complex information is simplified into a digital output, allowing counting of methylated and unmethylated alleles and providing an overall picture of methylation at the given locus. Downstream sequencing is minimised as dMS-HRM acts as a screen to select only methylated clones for further analysis. BioMed Central 2008-11-03 /pmc/articles/PMC2590600/ /pubmed/19014416 http://dx.doi.org/10.1186/1756-8935-1-7 Text en Copyright © 2008 Candiloro et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology
Candiloro, Ida LM
Mikeska, Thomas
Hokland, Peter
Dobrovic, Alexander
Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene
title Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene
title_full Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene
title_fullStr Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene
title_full_unstemmed Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene
title_short Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene
title_sort rapid analysis of heterogeneously methylated dna using digital methylation-sensitive high resolution melting: application to the cdkn2b (p15) gene
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2590600/
https://www.ncbi.nlm.nih.gov/pubmed/19014416
http://dx.doi.org/10.1186/1756-8935-1-7
work_keys_str_mv AT candiloroidalm rapidanalysisofheterogeneouslymethylateddnausingdigitalmethylationsensitivehighresolutionmeltingapplicationtothecdkn2bp15gene
AT mikeskathomas rapidanalysisofheterogeneouslymethylateddnausingdigitalmethylationsensitivehighresolutionmeltingapplicationtothecdkn2bp15gene
AT hoklandpeter rapidanalysisofheterogeneouslymethylateddnausingdigitalmethylationsensitivehighresolutionmeltingapplicationtothecdkn2bp15gene
AT dobrovicalexander rapidanalysisofheterogeneouslymethylateddnausingdigitalmethylationsensitivehighresolutionmeltingapplicationtothecdkn2bp15gene